Development and validation of a liquid chromatography-mass spectrometry assay for hair analysis of methylphenidate

Forensic Science International

Volumn 176, Issue 1, 2008, Pages 42-46

  Marchei, E ^a   Munoz J A ^b   García Algar, Ó ^b   Pellegrini, M ^a   Vall, O ^b   Zuccaro, P ^a   Pichini, S ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Hair; LC MS; Methylphenidate

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; HYDROCHLORIC ACID; METHYLPHENIDATE; PHOSPHATE BUFFERED SALINE; SODIUM HYDROXIDE;

ARTICLE; CONTROLLED STUDY; DRUG HAIR LEVEL; ELECTROSPRAY; ENVIRONMENTAL TEMPERATURE; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

EID: 39449118933     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2007.06.024     Document Type: Article

References (22)

1. Cantwell D.P. Attention deficit disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry 35 (1996) 978-987
2. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry. 36 (1997) 85S-121S
3. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., and Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
4. Elia J., Ambrosini P.J., and Rapoport J.L. Treatment of attention-deficit-hyperactivity disorder. N. Engl. J. Med. 340 (1999) 780-788
5. Goldman L.S., Genel M., Bezman R.J., and Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 279 (1998) 1100-1107
6. Eichhorst J., Etter M., Lepage J., and Lehotay D.C. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods. Clin. Biochem. 37 (2004) 175-183
7. Markowitz J.S., Straughn A.B., Patrick K.S., DeVane C.L., Pestreich L., Lee J., Wang Y., and Muniz R. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Clin. Pharmacokinet. 42 (2003) 393-401
8. Lin S.N., Andrenyak D.M., Moody D.E., and Foltz R.L. Enantioselective gas chromatography-negative ion chemical ionization mass spectrometry for methylphenidate in human plasma. J. Anal. Toxicol. 23 (1999) 524-530
9. Soldin S.J., Chan Y.P., Hill B.M., and Swanson J.M. Liquid-chromatographic analysis for methylphenidate (Ritalin) in serum. Clin. Chem. 25 (1979) 401-404
10. Gualtieri C.T., Hicks R.E., Patrick K., Schroeder S.R., and Breese G.R. Clinical correlates of methylphenidate blood levels. Ther. Drug Monit. 6 (1984) 379-392
11. Kimko H.C., Cross J.T., and Abernethy D.R. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin. Pharmacokinet. 37 (1999) 457-470
12. Bailey B., Klein J., and Koren G. Noninvasive methods for drug measurement in pediatrics. Pediatr. Clin. N. Am. 44 (1997) 15-26
13. La lande M., Wilson D.L., and VcGilveray I.J. HPLC determination of methylphenidate in human plasma. J. Liq. Chromatogr. 10 (1987) 2257-2264
14. Bach G.A., and Henion J. Quantitative capillary electrophoresis-ion-trap mass spectrometry determination of methylphenidate in human urine. J. Chromatogr. B: Biomed. Sci. Appl. 707 (1998) 275-285
15. Leis H.J., Fauler G., Raspotnig G., and Windischhofer W. Negative ion chemical ionization for the determination of methylphenidate in human plasma by stable isotope dilution gas chromatography/mass spectrometry. J. Mass Spectrom. 35 (2000) 1100-1104
16. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, May 2001 (http://www.fda.gov/cder/guidance/4252fnl.htm).
17. Skopp G., Potsch L., and Moeller M.R. On cosmetically treated hair-aspects and pitfalls of interpretation. For. Sci. Int. 84 (1997) 43-52
18. Potsch L., Skopp G., and Moeller M.R. Biochemical approach on the conservation of drug molecules during hair fiberformation. For. Sci Int. 84 (1997) 25-35
19. Jurado C., Kintz P., Menendez M., and Repetto M. Influence of the cosmetic treatment of hair on drug testing. Int. J. Legal Med. 110 (1997) 159-163
20. Williams J., Patsalos P.N., and Wilson J.F. Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy. For. Sci. Int. 84 (1997) 113-122
21. Gau S.S., Shen H.Y., Chou M.C., Tang C.S., Chiu Y.N., and Gau C.S. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J. Child Adolesc. Psychopharmacol. 16 (2006) 286-297
22. Pragst F., and Balikova M.A. State of the art in hair analysis for detection of drug and alcohol abuse. Clin. Chim. Acta 370 (2006) 17-49